npj Parkinsons Disease

Papers
(The H4-Index of npj Parkinsons Disease is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation362
Incidence of Parkinson disease in North America95
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease79
Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management74
Toward therapeutic electrophysiology: beta-band suppression as a biomarker in chronic local field potential recordings66
Dynamic control of the dopamine transporter in neurotransmission and homeostasis65
Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation64
Multi-modality machine learning predicting Parkinson’s disease63
Neuroimaging evidence of glymphatic system dysfunction in possible REM sleep behavior disorder and Parkinson’s disease63
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies61
A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease60
Subthalamic and pallidal deep brain stimulation for Parkinson’s disease—meta-analysis of outcomes60
Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study59
The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study59
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes57
How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review57
Probiotics synergized with conventional regimen in managing Parkinson’s disease54
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?54
Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease53
A systematic review on exercise and training-based interventions for freezing of gait in Parkinson’s disease52
Mechanisms of peripheral levodopa resistance in Parkinson’s disease51
Gait speed in clinical and daily living assessments in Parkinson’s disease patients: performance versus capacity49
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology48
Timing variability and midfrontal ~4 Hz rhythms correlate with cognition in Parkinson’s disease47
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients46
Diffusion along perivascular spaces as marker for impairment of glymphatic system in Parkinson’s disease45
Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson’s disease42
Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease42
Stress and mindfulness in Parkinson’s disease – a survey in 5000 patients41
Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis41
The role of brain perivascular space burden in early-stage Parkinson’s disease41
A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population41
Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity40
Diurnal modulation of subthalamic beta oscillatory power in Parkinson’s disease patients during deep brain stimulation38
Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation37
A systematic review and meta-analysis of inflammatory biomarkers in Parkinson’s disease37
Perspective on the current state of the LRRK2 field36
Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei36
Mining imaging and clinical data with machine learning approaches for the diagnosis and early detection of Parkinson’s disease36
Lewy body disease or diseases with Lewy bodies?36
Early constipation predicts faster dementia onset in Parkinson’s disease36
0.506098985672